THC Farmaceuticals, Inc.
CBDG · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $2 | $19 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $15 | $636 | $635 | $631 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $25 | $25 | $25 |
| Total Curr. Assets | $16 | $663 | $679 | $658 |
| Property Plant & Equip (Net) | $18 | $23 | $6 | $7 |
| Goodwill | $1,007 | $0 | $0 | $1,007 |
| Intangibles | $634 | $1,641 | $1,016 | $1,016 |
| Long-Term Investments | $1,072 | $450 | $1,095 | $645 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$1,007 |
| Total NC Assets | $2,730 | $2,113 | $2,117 | $1,668 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,746 | $2,776 | $2,796 | $2,326 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $30 | $30 |
| Short-Term Debt | $142 | $142 | $373 | $343 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $185 | $179 |
| Total Curr. Liab. | $142 | $142 | $588 | $551 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $142 | $142 | $588 | $551 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $0 |
| Common Stock | $18 | $18 | $18 | $17 |
| Retained Earnings | -$1,448 | -$1,433 | -$1,860 | -$1,852 |
| AOCI | $645 | $645 | $645 | $645 |
| Other Equity | $3,984 | $3,984 | $3,984 | $3,537 |
| Total Equity | $3,200 | $3,215 | $2,788 | $2,347 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$596 | -$581 | -$580 | -$572 |
| Total Liab. & Tot. Equity | $2,746 | $2,776 | $2,796 | $2,326 |
| Net Debt | $140 | $140 | $354 | $340 |